Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
Soo‐Young Na, Chang Hwan Choi, Eun Mi Song, et al.
Intestinal Research (2022) Vol. 21, Iss. 1, pp. 61-87
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
June Hwa Bae, Jung-Bin Park, Ji Eun Baek, et al.
Gut and Liver (2024) Vol. 18, Iss. 4, pp. 667-676
Open Access | Times Cited: 5
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Hyuk Yoon, Byong Duk Ye, Sang‐Bum Kang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
Xinqiao Chu, Yaning Biao, Chengjiang Liu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Comparison of 1‐Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study
Luan Minh Dang, Eun Soo Kim, Kyeong Ok Kim, et al.
JGH Open (2025) Vol. 9, Iss. 2
Open Access
Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease
Min Kyu Kim, Seung Hwan Shin, Cheol-Hyung Lee, et al.
Journal of Gastroenterology (2025)
Closed Access
Metabolic musculoskeletal disorders in patients with inflammatory bowel disease
Young Joo Yang, Seong Ran Jeon
The Korean Journal of Internal Medicine (2025) Vol. 40, Iss. 2, pp. 181-195
Open Access
Annual Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease During Infliximab Maintenance Therapy: Balancing Efficacy with Risk of Pharmacokinetic Failure
Yujin Lim, Boram Park, Kyeongman Jeon, et al.
Digestive Diseases and Sciences (2025)
Open Access
Does statin have a chemopreventive effect in patients with ulcerative colitis?
Yoon Suk Jung
Intestinal Research (2025) Vol. 23, Iss. 2, pp. 113-114
Open Access
Herpes zoster infection in patients with inflammatory bowel disease
Dong‐Hyun Kim, Sang‐Bum Kang
The Korean Journal of Internal Medicine (2025) Vol. 40, Iss. 3, pp. 347-356
Open Access
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease
Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, et al.
Journal of Gastroenterology (2025)
Open Access
Optimizing Infliximab Use in Real-World Inflammatory Bowel Disease: Insights from a Population Pharmacokinetic Model Integrating Intravenous and Subcutaneous Formulations
Sung Hoon Jung, Sang‐Bum Kang
Gut and Liver (2025) Vol. 19, Iss. 3, pp. 299-300
Closed Access
Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, et al.
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 9
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
You Sun Kim, Edward Hurley, Yoojeong Park, et al.
Intestinal Research (2023) Vol. 21, Iss. 4, pp. 420-432
Open Access | Times Cited: 9
Continued JAK inhibitor treatment on the risk of recurrent herpes zoster reactivation in patients with immune-mediated inflammatory diseases: A nationwide population-based study in South Korea
Young‐Eun Kim, Ye‐Jee Kim, Dae Hyun Jeong, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 65, pp. 152362-152362
Closed Access | Times Cited: 3
10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
Hee Moon Koo, Yu Kyung Jun, Yonghoon Choi, et al.
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 7
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
Jung-Bin Park, So Jung Han, Seung Bum Lee, et al.
Yonsei Medical Journal (2024) Vol. 65, Iss. 5, pp. 265-265
Open Access | Times Cited: 2
Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches
Sara Lauricella, Francesco Brucchi, Federica Cavalcoli, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 580-580
Open Access | Times Cited: 2
Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study
Min Jee Kim, Ye‐Jee Kim, Daehyun Jeong, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 2
Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments
Tomás Gabriel Bas, Vannessa Duarte
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 925-925
Open Access | Times Cited: 2
Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study
Ji-Eun Na, Yong-Eun Park, Jongha Park, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1066-1066
Open Access | Times Cited: 2
Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease
Hyuk Yoon, Sunghyouk Park, Yu Kyung Jun, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2882-2882
Open Access | Times Cited: 4
Clinical Significance of Prognostic Nutrition Index in Patients with Crohn’s Disease after Primary Bowel Resection
Hyeon Woo Bae, Yong Joon Lee, Min Young Park, et al.
Yonsei Medical Journal (2024) Vol. 65, Iss. 7, pp. 380-380
Open Access | Times Cited: 1
Deep Learning Model Using Stool Pictures for Predicting Endoscopic Mucosal Inflammation in Patients With Ulcerative Colitis
Jung Won Lee, Dongwon Woo, Kyeong Ok Kim, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 1
Prevalence and risk factors for gallstone and renal stone formation in patients with intestinal Behçet’s disease
Jae-Won Song, Soo Jung Park, Jae Jun Park, et al.
The Korean Journal of Internal Medicine (2024) Vol. 39, Iss. 5, pp. 770-782
Open Access | Times Cited: 1
Ganjiang Huangqin Huanglian Renshen Decoction Protects Against Ulcerative Colitis by Modulating Inflammation, Oxidative Stress, and Gut Microbiota
Ce Zhou, Bo Peng, Mingxing Zhang, et al.
Phytomedicine (2024) Vol. 135, pp. 156172-156172
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top